Manish Sisodia, hospitalised for COVID, also contracts dengue; doctors say 'no standard protocol' for treatment

Medical Director of Rajiv Gandhi Super Speciality Hospital (RGSSH) BL Sherwal said both the diseases have no specific treatment, which makes it even difficult for treating doctors of such patients.

Press Trust of India September 25, 2020 16:41:34 IST
Manish Sisodia, hospitalised for COVID, also contracts dengue; doctors say 'no standard protocol' for treatment

File image of Delhi deputy CM Manish Sisodia. PTI

Delhi deputy chief minister Manish Sisodia was diagnosed with dengue on Thursday, a day after he was hospitalised due to COVID-19. The deputy chief minister's platelet count has also reportedly dropped.

Sisodia was admitted to Lok Nayak Jai Prakash Narayan (LNJP) Hospital in New Delhi on Wednesday. He was initially kept under home isolation after he had contracted the COVID-19 infection.

On Thursday evening, the 48-year-old AAP leader was shifted to the ICU of Max Hospital Saket.

He had tested positive for COVID-19 on 14 September and is perhaps the first prominent personality in the city to have been diagnosed with both infections.

Meanwhile, doctors have said that Sisodia's treatment plan could be tricky as there is "no standard protocol" for treatment of patients who have contracted a double infection of COVID-19 and dengue, and a very "finely balanced" approach is needed to tackle both the ailments at once.

Medical Director of Rajiv Gandhi Super Speciality Hospital (RGSSH) BL Sherwal said both the diseases have no specific treatment, which makes it even difficult for treating doctors of such patients.

"Both COVID-19 and dengue need symptomatic treatment and in some aspects the treatment is kind of contradictory and thus tricky. In COVID-19, we inject heparin drug subcutaneously which ultimately reaches the blood stream, and this is done to prevent embolism in these patients which can prove fatal," he told PTI. 

Embolism is the sudden blocking of an artery which can obstruct flow of oxygen, and that is why some patients get complications even after treatment, the doctor said. RGSSH is a dedicated COVID-19 facility run by the Delhi government.

"In dengue, on the other hand, platelets infusion is needed in cases where its count has fallen to a dangerously low level. So, it's kind of opposite. And, therefore, we can't inject heparin if a COVID-19 patient has dengue too," Sherwal said.

So, for a doctor it is like "walking a tight rope" and a very "finely balanced approach" is needed, he said.

Sources at LNJP Hospital told PTI that "there is no standard protocol" for treatment of double infection of COVID-19 and dengue, and treatment is "patient-specific". LNJP Hospital is the largest hospital under Delhi government and is also a dedicated COVID-19 facility.

"The patient's age, condition, co-morbidities and other factors are taken into account for treatment of both the ailments," a source said.

Asked if there are any side effects of treatments in cases of a "double infection", the source said, "any treatment can have a side effect, but the treating doctor decides the methodology for it".

A dengue patient, if his or her platelets level falls dangerously below the normal level, needs external platelets infusion. A normal platelets level is considered in the range of 1.5-4.5 lakh, according to doctors.

"If a patient needs plasma for COVID-19 treatment, he can be administered that, and if he needs platelets that too can be infused. The treating doctor will decide the course of treatment," the source said.

Common symptoms of COVID-19 are high fever, breathlessness, cough, body fatigue and loss of sense of smell and taste.

In dengue, a vector-born disease caused by aedes agypti mosquito, a person runs high fever, suffers red rashes on skin, pain behind eye sockets, joint pain and in serious case internal bleeding which can prove fatal.

"In about 10 percent of dengue cases, a patient suffers haemorrhagic fever which leads to deaths. Internal bleeding can manifest through nose, gums and those are danger signs," Sherwal said.

Recently, Delhi health minister Satyendar Jain, himself a COVID-19 survivor, had told reporters that about 2-3 patients of COVID-19 in Delhi had shown dengue infection too.

"We have managed to contain dengue the year. Our campaign '10 Hafte 10 Baje 10 Minute' was very effective last year, and this year too dengue situation in Delhi is in control," he had said.

Updated Date:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

India's COVID-19 tally over 67.57 lakh with 72,049 fresh infections; fatality rate at 1.55%
India

India's COVID-19 tally over 67.57 lakh with 72,049 fresh infections; fatality rate at 1.55%

There are 9,07,883 active cases of coronavirus in the country which comprises 13.44 percent of the total caseload, said the health ministry

After COVID-19 lockdown, Mumbai Metro gets tepid response; schools partially reopen in UP, Punjab, Sikkim
India

After COVID-19 lockdown, Mumbai Metro gets tepid response; schools partially reopen in UP, Punjab, Sikkim

China, where the pandemic began in December, became the first major economy to return to growth with a 3.2 percent expansion in the quarter ending in June

COVID-19 cases may spike in winter, experts warn; hopeful of vaccine by 2021, says Harsh Vardhan
India

COVID-19 cases may spike in winter, experts warn; hopeful of vaccine by 2021, says Harsh Vardhan

Dr VK Paul, a member of NITI Aayog said the novel coronavirus is a respiratory virus and these kinds of viruses attack more during the winters